Claim

0

Aromatic Amino Acid Fluorescence Degradation

astrobiologyradiolysisamino acidsfluorescence

Evidence

Statement

At 50 kGy gamma radiation, aromatic amino acid fluorescence (tyrosine, phenylalanine) is reduced to 9–25% of original intensity, while PAH fluorescence retains ~50%.

Evidence

Blanco et al. 2018, Astrobiology 18(12):1497–1516. DOI: 10.1089/ast.2016.1645

Quantitative data at 50 kGy gamma:

  • Tyrosine-BSA: 25% retained (75% loss)
  • Phenylalanine derivative: 9% retained (91% loss)
  • Benzo-a-pyrene-BSA (PAH): 51% retained (49% loss)

Two-pathway radiolysis model: N/N₀ = A·exp(−k₁·D) + B·exp(−k₂·D), where A = 0.649, k₁ = 0.00288 kGy⁻¹, B = 0.351, k₂ = 0.202 kGy⁻¹ (gamma). The fast pathway (k₂) is exhausted by 50 kGy; from 50–100 kGy only the slow pathway (k₁) operates, reducing retention to approximately 87% of the 50 kGy values.

Cross-reference: Bhartia et al., 2010, Applied and Environmental Microbiology 76(21):7231–7237. DOI: 10.1128/AEM.00943-10 Established that DUV native fluorescence detection of bacteria depends on intact aromatic fluorophores (tyrosine, tryptophan at λmax 325–341 nm).

Argument

A1: Dose extrapolation is conservative. Blanco et al. measured at 50 kGy; the two-pathway model predicts continued degradation at 100 kGy. Since the fast pathway is already exhausted, the remaining slow pathway reduces 50 kGy retention values by an additional ~13%. The direction is unambiguous.

A2: Differential degradation creates systematic bias. Biological aromatics (tyrosine, phenylalanine) degrade 2–5× faster than abiotic PAHs. This asymmetry means post-irradiation fluorescence ratios systematically underrepresent biological contributions.

Implication

Biological aromatics degrade faster than abiotic PAHs. Supports "Affected" for:

  • FLUORESCENCE SPECTROSCOPY × SCI 2.2 (Biosignatures)
  • FLUORESCENCE SPECTROSCOPY × SSA 1.2 (Abiotic Baseline)

Links

Concept Home
Workbook
Report

Reviews

The following reviews are limited in scope to the validity of the claim made above, and do not imply that the reviewer has taken a position regarding any other claim or the overall feasibility of a concept that is supported by this claim.

No reviews yet.